Wakefit IPO Day 1: Slow subscription, check GMP – Will you subscribe?

Wakefit’s IPO opened to a subdued 11% Day 1 subscription, with retail showing moderate interest and institutions staying away. Despite a positive GMP hinting at a premium listing, concerns persist over ongoing losses, high costs and limited operating leverage.